Brad A. Marder

1.7k total citations
33 papers, 1.4k citations indexed

About

Brad A. Marder is a scholar working on Nephrology, Transplantation and Surgery. According to data from OpenAlex, Brad A. Marder has authored 33 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Nephrology, 11 papers in Transplantation and 9 papers in Surgery. Recurrent topics in Brad A. Marder's work include Gout, Hyperuricemia, Uric Acid (12 papers), Renal Transplantation Outcomes and Treatments (11 papers) and Liver Disease and Transplantation (4 papers). Brad A. Marder is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (12 papers), Renal Transplantation Outcomes and Treatments (11 papers) and Liver Disease and Transplantation (4 papers). Brad A. Marder collaborates with scholars based in United States, Spain and Brazil. Brad A. Marder's co-authors include W.F. Morgan, William F. Morgan, Laure Sabatier, John P. Murnane, Barbara Murphy, Bernd Schröppel, Michael Fischereder, Pushkal Garg, William H. Marks and Mamta Agarwal and has published in prestigious journals such as The EMBO Journal, Molecular and Cellular Biology and Journal of the American Society of Nephrology.

In The Last Decade

Brad A. Marder

33 papers receiving 1.4k citations

Peers

Countries citing papers authored by Brad A. Marder

Since Specialization

Citations

This map shows the geographic impact of Brad A. Marder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brad A. Marder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brad A. Marder more than expected).

Fields of papers citing papers by Brad A. Marder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brad A. Marder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brad A. Marder. The network helps show where Brad A. Marder may publish in the future.

Co-authorship network of co-authors of Brad A. Marder

This figure shows the co-authorship network connecting the top 25 collaborators of Brad A. Marder. A scholar is included among the top collaborators of Brad A. Marder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brad A. Marder. Brad A. Marder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Quality of life improvements and clinical assessments in kidney transplant recipients undergoing pegloticase treatment for uncontrolled gout: findings of the phase 4 PROTECT clinical trial 2025 ·Frontiers in Immunology ·Abdul Abdellatif, (unknown), K. Obermeyer, (unknown), Brad A. Marder, John D. Scandling	1
2	Prevalence and Influence of Gout in Patients with Advanced Chronic Kidney Disease: Findings of a Large Retrospective Chart Review 2024 ·MDPI (MDPI AG) ·Leonard Stern, Richard J. Johnson, (unknown), (unknown), Lissa Padnick‐Silver, Brian LaMoreaux, Brad A. Marder, Sreedhar Mandayam	4
3	Intensive urate-lowering with pegloticase plus methotrexate co-therapy in uncontrolled gout patients with and without chronic kidney disease: A retrospective case series 2024 ·Medicine ·(unknown), (unknown), Lissa Padnick‐Silver, Brad A. Marder, Brian LaMoreaux	1
4	Projected Health and Economic Burden of Comorbid Gout and Chronic Kidney Disease in a Virtual US Population: A Microsimulation Study 2024 ·Rheumatology and Therapy ·(unknown), Lise Retat, (unknown), Brad A. Marder, Lissa Padnick‐Silver, Brian LaMoreaux, (unknown)	3
5	Pegloticase efficacy and safety in kidney transplant recipients; results of the phase IV, open‐label PROTECT clinical trial 2023 ·Clinical Transplantation ·Abdul Abdellatif, (unknown), Jason Chamberlain, (unknown), (unknown), Brad A. Marder, John D. Scandling, Kenneth G. Saag	5
6	Blood Pressure Changes with Intensive Urate Lowering in Uncontrolled Gout Patients with and Without CKD 2023 ·Journal of the American Society of Nephrology ·Brad A. Marder, Richard J. Johnson, Hyon K. Choi, (unknown), Brian LaMoreaux, Peter E. Lipsky	1
7	eGFR Changes in Uncontrolled Gout Patients Randomized to Receive Methotrexate or Placebo as Co-Therapy to Pegloticase: MIRROR RCT Findings 2022 ·Journal of the American Society of Nephrology ·Abdul Abdellatif, (unknown), (unknown), Brian LaMoreaux, Brad A. Marder	1
8	DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS 2018 ·Journal of the American Society of Nephrology ·Howard Trachtman, Peter J. Nelson, Sharon G. Adler, Kirk N. Campbell, Abanti Chaudhuri, Vimal K. Derebail, Giovanni Gambaro, Loreto Gesualdo, Debbie S. Gipson, Jonathan Hogan, Kenneth V. Lieberman, Brad A. Marder, Kevin Meyers, (unknown), Jai Radhakrishnan, Tarak Srivastava, (unknown), Vladimı́r Tesař, Olga Zhdanova, Radko Komers, (unknown)	129
9	Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients 2016 ·Transplantation Direct ·Hélio Tedesco‐Silva, V. Ram Peddi, Ana Sánchez‐Fructuoso, Brad A. Marder, Graeme Russ, Fritz Diekmann, (unknown), (unknown), Huihua Li, Michael A. Tortorici, Seth L. Schulman	12
10	Effect of Ramipril on Urinary Protein Excretion in Maintenance Renal Transplant Patients Converted to Sirolimus 2015 ·American Journal of Transplantation ·Didier A. Mandelbrot, Josefina Alberú, Azemi Barama, Brad A. Marder, (unknown), Stuart M. Flechner, (unknown), Cynthia G. Healy, (unknown), Michael A. Tortorici, Sam Schulman	16
11	Outcomes at 4 Years in a Randomized Trial Evaluating Belatacept-Based Regimens With Simultaneous CNI and Steroid-Avoidance in Kidney Transplant. 2014 ·Transplantation ·Josep M. Grinyó, Brad A. Marder, M. Harler, F. Vincenti, Franco Citterio, Uday Nori, E. Steve Woodle	1
12	Immunosuppression with Belatacept-Based, Corticosteroid-Avoiding Regimens in De Novo Kidney Transplant Recipients 2010 ·American Journal of Transplantation ·R M Ferguson, J.M. Grinyó, Flavio Vincenti, Dixon B. Kaufman, E. Steve Woodle, Brad A. Marder, Franco Citterio, William H. Marks, Mamta Agarwal, (unknown), Yuping Dong, Pushkal Garg	153
13	Genetic variability and transplantation 2003 ·Current Opinion in Urology ·Brad A. Marder, Bernd Schröppel, Barbara Murphy	31
14	The Impact of Costimulatory Molecule Gene Polymorphisms on Clinical Outcomes in Liver Transplantation 2003 ·American Journal of Transplantation ·Brad A. Marder, Bernd Schröppel, Marvin Lin, Thomas D. Schiano, Rulan S. Parekh, Yaron Tomer, Barbara Murphy	34
15	Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease 2003 ·Genes and Immunity ·Yoshio Ban, Terry F. Davies, David A. Greenberg, (unknown), Brad A. Marder, Barbara Murphy, E S Concepcion, Ronald Villanueva, Giuseppe Barbesino, Vincent Ling, Yaron Tomer	66
16	The Impact of Polymorphisms in Chemokine and Chemokine Receptors on Outcomes in Liver Transplantation 2002 ·American Journal of Transplantation ·Bernd Schröppel, Michael Fischereder, (unknown), Marvin Lin, Bernhard K. Krämer, Brad A. Marder, (unknown), Barbara Murphy	29
17	Analysis of Gene Polymorphisms in the Regulatory Region of MCP-1, RANTES, and CCR5 in Liver Transplant Recipients 2002 ·Journal of Clinical Immunology ·Bernd Schröppel, Michael Fischereder, Marvin Lin, Brad A. Marder, (unknown), Bernhard K. Krämer, Barbara Murphy	15
18	Telomeres and their possible role in chromosome stabilization 1993 ·Environmental and Molecular Mutagenesis ·Joseph Day, Brad A. Marder, William F. Morgan	36
19	Delayed Chromosomal Instability Induced by DNA Damage 1993 ·Molecular and Cellular Biology ·Brad A. Marder, William F. Morgan	253
20	Delayed chromosomal instability induced by DNA damage. 1993 ·Molecular and Cellular Biology ·Brad A. Marder, W.F. Morgan	183

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact